General Steps to Standardize the Laboratory Measurement of Serum Total 25-Hydroxyvitamin D

被引:49
|
作者
Sempos, Christopher T. [1 ]
Betz, Joseph M. [1 ]
Camara, Johanna E. [2 ]
Carter, Graham D. [3 ]
Cavalier, Etienne [4 ]
Clarke, Michael W. [5 ]
Dowling, Kirsten G. [6 ]
Durazo-Arvizu, Ramon A. [7 ]
Hoofnagle, Andrew N. [8 ]
Liu, Andy [9 ]
Phinney, Karen W. [10 ]
Sarafin, Kurtis [11 ]
Wise, Stephen A. [1 ,2 ]
Coates, Paul M. [1 ]
机构
[1] NIH, Off Dietary Supplements, Bldg 10, Bethesda, MD 20892 USA
[2] NIST, Chem Sci Div, Gaithersburg, MD 20899 USA
[3] Imperial Coll Healthcare NHS Trust, London, England
[4] Univ Liege, CHU Liege, Dept Clin Chem, Liege, Belgium
[5] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia
[6] Univ Coll Cork, Sch Food & Nutr Sci, Cork Ctr Vitamin & Nutr Res D, Cork, Ireland
[7] Loyola Univ Chicago, Dept Publ Hlth Sci, Chicago, IL USA
[8] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[9] Son Healthcare, Douglass Hanly Moir Pathol, Sydney, NSW, Australia
[10] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA
[11] Hlth Canada, Nutr Res Div, Ottawa, ON, Canada
关键词
TANDEM MASS-SPECTROMETRY; VITAMIN-D METABOLITES; D-3;
D O I
10.5740/jaoacint.17-0259
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The Vitamin D Standardization Program (VDSP) has collaborated with numerous groups and agencies to assemble a set of tools, i.e., a reference measurement system, that can be used to establish the traceability of 25-hydroxyvitamin D [25(OH)D] assays to relevant reference measurement procedures and reference materials. This is done with the goal of verifying end-user laboratory performance using precise statistical criteria to determine whether a specific assay is standardized. The purpose of this paper was to outline a set of steps that routine clinical and research laboratories can use to standardize their 25(OH)D assays using these tools. These steps apply to laboratories using commercially developed immunoassay measurement systems as well as in-house assays, usually based on high HPLC or LC tandem MS measurement systems. The steps are (1) initial calibration, (2) initial assessment of accuracy and bias, (3) assessment of total percent CV and mean bias, (4) use of trueness controls, and (5) participation in accuracy-based performance testing and/or external quality assessment schemes. The goal of each laboratory assay is to have a total CV of <= 10% and mean bias of 55%. Rigorous and less rigorous but low-cost options for meeting these statistical criteria are provided. Research laboratories who infrequently measure 25(OH)D are advised to repeat steps 1-4 for every measurement cycle. For users of commercial immunoassays who have relatively little control over standardization, we present an option for using trueness controls to develop a master equation that can be used to standardize results to the reference methods.
引用
收藏
页码:1230 / 1233
页数:4
相关论文
共 50 条
  • [1] MEASUREMENT OF 25-HYDROXYVITAMIN D3 IN SERUM
    BOUILLON, R
    VANKERKHOVE, P
    DEMOOR, P
    CLINICAL CHEMISTRY, 1976, 22 (03) : 364 - 368
  • [2] Measurement uncertainty for the analysis of serum 25-hydroxyvitamin D
    Stepman, H. C. M.
    Thienpont, L. M.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (06) : 1053 - 1053
  • [3] Measurement uncertainty for the analysis of serum 25-hydroxyvitamin D
    H. C. M. Stepman
    L. M. Thienpont
    Osteoporosis International, 2010, 21 : 1053 - 1053
  • [4] An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D
    Wagner, Dennis
    Hanwell, Heather E. C.
    Vieth, Reinhold
    CLINICAL BIOCHEMISTRY, 2009, 42 (15) : 1549 - 1556
  • [5] Serum free and bio-available 25-hydroxyvitamin D correlate better with bone density than serum total 25-hydroxyvitamin D
    Johnsen, Martin S.
    Grimnes, Guri
    Figenschau, Yngve
    Torjesen, Peter A.
    Almas, Bjorg
    Jorde, Rolf
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2014, 74 (03): : 177 - 183
  • [6] Measurement of 25-hydroxyvitamin D revisited
    Schmidt, Jane A.
    CLINICAL CHEMISTRY, 2006, 52 (12) : 2304 - 2305
  • [7] SERUM PTH CONCENTRATION IS RELATED TO TOTAL, BUT NOT BIOAVAILABLE, 25-HYDROXYVITAMIN D
    Binkley, N.
    Krueger, D.
    Fidler, E.
    Borchardt, G.
    Wiebe, D.
    Haller, I.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S337 - S337
  • [8] Lower total 25-hydroxyvitamin D but no difference in calculated or measured free 25-hydroxyvitamin D serum levels in patients with primary hyperparathyroidism
    Meng, Lingqiong
    Su, Chi
    Shapses, Sue A.
    Al-Dayyeni, Aseel
    He, Yuling
    Wang, Xiangbing
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2020, 199
  • [9] Serum 25-hydroxyvitamin D status in individuals with psoriasis in the general population
    Wilson, Patrick Benjamin
    ENDOCRINE, 2013, 44 (02) : 537 - 539
  • [10] Serum 25-hydroxyvitamin D status in individuals with psoriasis in the general population
    Patrick Benjamin Wilson
    Endocrine, 2013, 44 : 537 - 539